Literature DB >> 9352283

Relationship between retinal lesions and axial length, age and sex in high myopia.

N Gözüm1, M Cakir, A Gücukoglu, F Sezen.   

Abstract

We analysed the relationship between central and peripheral retinal lesions and axial length (AL), patient's age and sex with myopia greater than 6 diopters. A total of 212 eyes of 109 patients with high myopia underwent detailed funduscopy and A-scan ultrasonography. AL was measured, and central and peripheral retinal lesions were noted. Results were analysed using Student's t-test. Sixty-one patients (118 eyes) were female and 48 (94 eyes) male. Mean age was 31.00 +/- 13.67 years, and mean AL was 28.31 +/- 2.02 mm. Chorioretinal atrophy, Fuchs' spot, posterior staphyloma and posterior vitreous detachment increased significantly with AL and age. Fuchs' spot was more common in females. White-without-pressure (WWP) was inversely correlated with AL and age, and was more common in males. The high frequency of WWP in younger patients and moderate AL suggests that these lesions result from vitreoretinal tractions. Lattice degeneration was also a frequent finding in high myopia, and tended to increase with AL and age, though without reaching statistical significance.

Entities:  

Mesh:

Year:  1997        PMID: 9352283     DOI: 10.1177/112067219700700313

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   1.922


  16 in total

1.  Fundus characteristics of high myopia in children.

Authors:  Kanako Kobayashi; Kyoko Ohno-Matsui; Ariko Kojima; Noriaki Shimada; Kenjiro Yasuzumi; Takeshi Yoshida; Soh Futagami; Takashi Tokoro; Manabu Mochizuki
Journal:  Jpn J Ophthalmol       Date:  2005 Jul-Aug       Impact factor: 2.447

2.  Prevalence and characteristics of peripheral myopic retinopathy in Guangzhou office workers.

Authors:  Ting Zhang; Yan-Tao Wei; Wen-Bin Huang; Rong-Jiao Liu; Ya-Jing Zuo; Li-Wen He; Li-Ting Zhong; Shao-Chong Zhang
Journal:  Int J Ophthalmol       Date:  2018-08-18       Impact factor: 1.779

3.  Evaluation of structural and functional changes in non-pathologic myopic fundus using multifocal electroretinogram and optical coherence tomography.

Authors:  Saemi Park; Seung Hoon Kim; Tae Kwann Park; Young-Hoon Ohn
Journal:  Doc Ophthalmol       Date:  2013-03-08       Impact factor: 2.379

4.  Electrophysiological study of myopia.

Authors:  Mona Abdel Kader
Journal:  Saudi J Ophthalmol       Date:  2011-08-16

5.  Reduced-fluence verteporfin photodynamic therapy plus ranibizumab for choroidal neovascularization in pathologic myopia.

Authors:  M Rinaldi; F Semeraro; F Chiosi; A Russo; M R Romano; M C Savastano; R dell'Omo; C Costagliola
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-09-28       Impact factor: 3.117

6.  Aqueous humor concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in high myopic patients.

Authors:  Young Joo Shin; Woo Ho Nam; Soo Eun Park; Joo Hyun Kim; Ha Kyoung Kim
Journal:  Mol Vis       Date:  2012-08-14       Impact factor: 2.367

7.  Posterior Scleral Reinforcement to Prevent Progression of High Myopia.

Authors:  Weilin Huang; Anli Duan; Yue Qi
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2019 Sep-Oct

8.  Clinical profile and distribution of peripheral retinal changes in myopic population in a hospital-based study in North India.

Authors:  Neelam Khatwani; Sandhya Makhija; Ashish Ahuja
Journal:  Indian J Ophthalmol       Date:  2022-04       Impact factor: 2.969

9.  Patterns of posterior ocular complications in myopic eyes of Indian population.

Authors:  Rohit Dhakal; Abhilash Goud; Raja Narayanan; Pavan K Verkicharla
Journal:  Sci Rep       Date:  2018-09-12       Impact factor: 4.379

10.  The Prevalence and Associations of Peripheral Retinopathy: Baseline Study of Guangzhou Office Computer Workers.

Authors:  Ting Zhang; Yajing Zuo; Yantao Wei; Wenbin Huang; Xuezhi Zhou; Rongjiao Liu; Lili Zhong; Manjuan Peng; Shaochong Zhang
Journal:  J Ophthalmol       Date:  2018-06-20       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.